Literature DB >> 9870253

Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders.

M Rowe1, G Niedobitek, L S Young.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9870253     DOI: 10.1007/bf00838051

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  71 in total

1.  Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.

Authors:  G Niedobitek; A Agathanggelou; H Herbst; L Whitehead; D H Wright; L S Young
Journal:  J Pathol       Date:  1997-06       Impact factor: 7.996

2.  Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.

Authors:  M J Maunders; L Petti; M Rowe
Journal:  J Gen Virol       Date:  1994-04       Impact factor: 3.891

3.  Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort.

Authors:  Q Y Yao; D S Croom-Carter; R J Tierney; G Habeshaw; J T Wilde; F G Hill; C Conlon; A B Rickinson
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.

Authors:  M Rowe; L S Young; K Cadwallader; L Petti; E Kieff; A B Rickinson
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations.

Authors:  F Khanim; Q Y Yao; G Niedobitek; S Sihota; A B Rickinson; L S Young
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

6.  Sequence variation in the Epstein-Barr virus latent membrane protein 1.

Authors:  W E Miller; R H Edwards; D M Walling; N Raab-Traub
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

7.  Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. French Study Group of Pathology for HIV-associated Tumors.

Authors:  D Rea; H J Delecluse; S J Hamilton-Dutoit; L Marelle; I Joab; L Edelman; J F Finet; M Raphael
Journal:  Ann Oncol       Date:  1994       Impact factor: 32.976

8.  Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.

Authors:  M L Chen; C N Tsai; C L Liang; C H Shu; C R Huang; D Sulitzeanu; S T Liu; Y S Chang
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

9.  Hodgkin's disease after transplantation.

Authors:  J L Garnier; Y Lebranchu; J Dantal; J Bedrossian; R Cahen; D Assouline; A Jaccard; F Fetissoff; A Moreau; X Martin; G Delsol; F Berger; J L Touraine
Journal:  Transplantation       Date:  1996-01-15       Impact factor: 4.939

10.  Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.

Authors:  D Frank; E Cesarman; Y F Liu; R E Michler; D M Knowles
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

View more
  5 in total

1.  Chronic herpesvirus reactivation occurs in aging.

Authors:  Raymond P Stowe; Elena V Kozlova; Deborah L Yetman; Dennis M Walling; James S Goodwin; Ronald Glaser
Journal:  Exp Gerontol       Date:  2007-01-30       Impact factor: 4.032

2.  Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens.

Authors:  N Meru; S Davison; L Whitehead; A Jung; D Mutimer; N Rooney; D Kelly; G Niedobitek
Journal:  Mol Pathol       Date:  2001-08

3.  Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopes.

Authors:  Do Nguyen-Van; Colm Keane; Erica Han; Kimberley Jones; Jamie P Nourse; Frank Vari; Nathan Ross; Pauline Crooks; Olivier Ramuz; Michael Green; Lyn Griffith; Ralf Trappe; Andrew Grigg; Peter Mollee; Maher K Gandhi
Journal:  Am J Blood Res       Date:  2011-09-09

4.  Surface immunoglobulin-deficient Epstein-Barr virus-infected B cells in the peripheral blood of pediatric solid-organ transplant recipients.

Authors:  Elizabeth Schauer; Steven Webber; Michael Green; David Rowe
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

5.  EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression--a case report.

Authors:  Alexander Krenauer; Alexander Moll; Wolfram Pönisch; Nicole Schmitz; Gerald Niedobitek; Dietger Niederwieser; Thomas Aigner
Journal:  Diagn Pathol       Date:  2010-03-31       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.